Arcadia Biosciences, Inc.
RKDA
$0.47
$0.000.23%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | -11.13M | -9.32M | -2.34M | -5.07M | -7.54M |
| Total Depreciation and Amortization | 17.00K | 45.00K | 154.00K | 323.00K | 473.00K |
| Total Amortization of Deferred Charges | 0.00 | 421.00K | -- | -- | -- |
| Total Other Non-Cash Items | 7.45M | 4.31M | -2.53M | -342.00K | 1.55M |
| Change in Net Operating Assets | 1.13M | 293.00K | -26.00K | -1.00M | -2.07M |
| Cash from Operations | -2.54M | -4.25M | -4.74M | -6.09M | -7.58M |
| Capital Expenditure | -- | -- | -- | 0.00 | 0.00 |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -8.00K | 172.00K |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 0.00 | 250.00K | 750.00K | 3.27M | 3.27M |
| Cash from Investing | 0.00 | 250.00K | 750.00K | 3.27M | 3.45M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 6.08M | 1.00K | 6.00K | 6.00K | 9.00K |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -745.00K | 1.79M | -- | -- | -- |
| Cash from Financing | 5.34M | 1.80M | 6.00K | 6.00K | 9.00K |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 2.80M | -2.21M | -3.98M | -2.82M | -4.13M |